SunWay Biotech Co., LTD. (1271.TWO)
- Previous Close
117.50 - Open
116.50 - Bid 115.50 x --
- Ask 117.00 x --
- Day's Range
115.50 - 119.50 - 52 Week Range
47.30 - 145.50 - Volume
152,153 - Avg. Volume
183,027 - Market Cap (intraday)
3.939B - Beta (5Y Monthly) -0.05
- PE Ratio (TTM)
78.91 - EPS (TTM)
1.47 - Earnings Date --
- Forward Dividend & Yield 1.00 (0.86%)
- Ex-Dividend Date Apr 11, 2024
- 1y Target Est
--
SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.
sunway.cc--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 1271.TWO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1271.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1271.TWO
Valuation Measures
Market Cap
3.94B
Enterprise Value
3.88B
Trailing P/E
78.91
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.09
Price/Book (mrq)
1.23
Enterprise Value/Revenue
6.79
Enterprise Value/EBITDA
46.49
Financial Highlights
Profitability and Income Statement
Profit Margin
29.37%
Return on Assets (ttm)
9.35%
Return on Equity (ttm)
19.26%
Revenue (ttm)
322.17M
Net Income Avi to Common (ttm)
94.6M
Diluted EPS (ttm)
1.47
Balance Sheet and Cash Flow
Total Cash (mrq)
282.22M
Total Debt/Equity (mrq)
56.59%
Levered Free Cash Flow (ttm)
-83.39M
Company Insights: 1271.TWO
1271.TWO does not have Company Insights